China, Oct. 14 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'ASC22 combined with Peg-IFNa in achieving functional cure in patients with chronic hepatitis B virus infection'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134327
Registration Time: 2026/10/13
Type: Interventional study
Primary Sponsor: The 2nd Affiliated Hospital of Chongqing Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=230008
Published by HT Digital Content Services with permission from Health Daily Digest....